Your Input Creates a Better Understanding of Immunoglobulin (Ig) Replacement Therapy
The IDF 2018 National Ig Treatment Experiences and Preferences Survey will be released in September 2018 and will be mailed to randomly selected households in the IDF community. This survey specifically focuses on individuals’ experience with intravenous immunoglobulin replacement therapy (IVIG), subcutaneous immunoglobulin replacement therapy (SCIG), and intramuscular immunoglobulin (IM) replacement therapy.
The results from our previous National Ig Treatment Experiences and Preferences Surveys, conducted in 1996, 2003, 2008 and 2013, have dramatically helped patients, families, healthcare providers and policymakers to better understand how Ig replacement therapy impacts the lives of individuals with PI.
We look forward to the results from this 5th National Ig Treatment Experiences and Preferences Survey, and we encourage you to share your experiences with IDF! Your participation will provide information that is vital to continue the mission of IDF—to improve the diagnosis, treatment and quality of life of people with PI.
Please be on the lookout for the IDF 2018 National Ig Treatment Experiences and Preferences Survey in your mailbox in the next few weeks. Now is the time to make sure your contact information is up-to-date, so we can contact you to share your experiences. We can’t e-mail you about our surveys unless you have an IDF My Account and are subscribed to “IDF Surveys.” If you do have an IDF My Account, log in, scroll down to “My E-mail Subscriptions” and subscribe to “IDF Surveys.” If you have not created an account yet, get started!
Participate for Your Chance to Win!
When you complete and return this survey, your household will be eligible to win either a $100, $200 or $700 Amazon eGift card! Your survey must be completed and returned to IDF not later than December 31, 2018 in order to be eligible to win one of the three eGift cards. The winning households will be notified in January 2019.
If have any questions about this survey project, click here to contact us.
This article originally appeared in the IDF monthly e-newsletter, Primary Immune Tribune. Click here to subscribe.